mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.03 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |